• FirefoxInstall the new Firefox »
  •  Dow Down 0.58% Nasdaq Down 0.26%

    Sarepta Therapeutics, Inc. (SRPT)

    -NasdaqGS
    14.05 Up 0.69(5.16%) 3:59PM EST
    |After Hours : 14.06 Up 0.01 (0.07%) 4:00PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:13.36
    Open:13.36
    Bid:14.02 x 600
    Ask:14.03 x 200
    1y Target Est:25.31
    Beta:1.75
    Earnings Date:May 6 - May 11 (Est.)
    Day's Range:13.15 - 14.07
    52wk Range:11.33 - 40.00
    Volume:774,233
    Avg Vol (3m):1,005,430
    Market Cap:580.42M
    P/E (ttm):N/A
    EPS (ttm):-3.39
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    SRPTUp 5.16%580.42M
    ALNYUp 0.15%8.97B
    GSKUp 0.27%115.08B
    ISISUp 2.16%8.29B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):56.57
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-4.04
    Quarterly EPS Est (Mar-15) :-0.99
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):16.55

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare and infectious diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback